This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Menon, Y Articles by McGrath, H Search for Related Content PubMed PubMed Citation Articles by Menon, Y Articles by McGrath, H, Jr Social Bookmarking                         What's this?

Reversal of brain dysfunction with UV-A1 irradiation in a patient with systemic lupus

Louisiana State University Medical School, New Orleans, Louisiana, USA

K McCarthy

Louisiana State University Medical School, New Orleans, Louisiana, USA

H McGrath, Jr

Louisiana State University Medical School, New Orleans, Louisiana, USA, hmcgra{at}lsuhsc.edu

Low-dose ultraviolet A-1 (UV-A1; 340-400nm) bodily irradiation significantly reduces clinical manifestations of systemic lupus erythematosus (SLE). As neuropsychiatric-likesymptoms respond prominently, a single patient was selected to undergo positron emission tomography (PET) before and after therapy to determine the effects of the therapy on the brain. The functional changes in ¹⁸F-deoxyglucose uptake as determined by PET imaging in this SLE patient indicated that improvement in brain function paralleled the reversal of cognitive deficits noted after the administration 160kJ of bodily UV-A1 irradiationadministeredthree times a week. Also of interest is that the UV-A1 irradiation, for the first time, ameliorated discoid lupus rashes, presumably due to a systemic action, as the lesions were for the first time covered during therapy.

Key Words: discoid lupus • neuropsychiatric lupus • positron emission tomography • systemic lupus erythematosus • ultraviolet-A1

Lupus, Vol. 12, No. 6, 479-482 (2003)
DOI: 10.1191/0961203303lu374oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Pavel Light therapy (with UVA-1) for SLE patients: is it a good or bad idea? Rheumatology, June 1, 2006; 45(6): 653 - 655. [Full Text] [PDF]

				H McGrath Jr Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient Lupus, October 1, 2005; 14(10): 859 - 861. [Abstract] [PDF]